spacer
home > pmps > spring 2018 > controlled conduct
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Controlled Conduct

PMPS: Can you explain the current prevalence of counterfeiting within the pharmaceutical industry?

Sandra Lee: The WHO estimate 15% of all medicines available worldwide are counterfeit, and, while this decreases to around 1% in the EU, it remains a significant risk to patient safety. As the demand for prescription medicines continues to rise, incentive and opportunity for counterfeiters to interfere with the legitimate supply chain increases.

Pharma manufacturers have been preparing for the adoption of the Falsified Medicines Directive (FMD), which will be enforced in February 2019, as this will provide added security within the supply chain. The additional safeguards of FMD will help protect against counterfeit medicines potentially reaching critically ill patients, such as the recently reported instances of oncology medicines for cancer patients.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sandra Lee has 35 years’ plus of operational, quality, and project management experience within the commercial and clinical pharma industry, gained through roles at past organisations such as Novartis, Boehringer Ingelheim, Fisher Clinical Services, and now Accord Healthcare. Currently, as the Managing Director of operations at Accord, she leads the manufacturing sites at Barnstaple and Haverhill. Sandra received her BSc in applied chemistry at Brighton Polytechnic, UK, has a post-graduate diploma in industrial pharmaceutical studies, and is also a Chartered Director.
spacer
Sandra Lee
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

RWS Life Sciences Welcomes New VP of Quality

RWS Life Sciences welcomes Clarice Streets, ASQ, CMQ, OE, as Vice President, Global Quality and Process, in charge of the strategic direction and implementation of its Quality system, underlying organizational processes, and change management.
More info >>

White Papers

Customising the Cold Chain

World Courier

Of all the statistics emerging around the global pharmaceutical industry this year, two big numbers capture the attention of both manufacturers and their logistics partners: $248 billion, the amount the “BRIC” nations (Brazil, Russia, India and China) are poised to account for in pharmaceutical sales for by 2016; and $8 billion, the amount global pharma will spend on cold chain logistics in 2014. Why are these two numbers so noteworthy? They demonstrate that as R&D goes, so goes logistics. As products evolve to meet demands for more targeted therapies, demand for more targeted logistics solutions grows as well. And that means a need for customization for everything from clinical trial samples to finished product.
More info >>

 
Industry Events

Pharma and Device Packaging and Labelling West Coast 2018

27-28 November 2018, Burlingame, CA

The second edition of the Pharma and Device Packaging and Labeling West Coast was a thought-provoking two days of engaging presentations, discussion and networking.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement